BCTX logo

BriaCell Therapeutics Corp. (BCTX)

Profile

Full Name

BriaCell Therapeutics Corp.

Ticker

NASDAQ: BCTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

March 14, 2012

Indexes

Not included

Website

http://briacell.com

Employees

16

Key Details

Price

$2.04(-1.43%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$4.35(+77.69% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.04
    BCTX price is $2.04

    30-Day Relative Volume

    2.25
    BCTX 30-day relative volume is 2.25

    Price Performance

    Price Today change

    -1.43%
    BCTX price is down -1.43% today

    Price YTD change

    +264.38%
    BCTX price is up +264.38% since January 1st

    Price 1-year change

    +124.23%
    BCTX price is up +124.23% year-on-year

    Price 3-year change

    -65.65%
    BCTX price is down -65.65% over the past 3 years

    Price Range

    Price All-time high

    $156.35
    BCTX price is currently -98.69% below its historical high of $156.35

    Price 3-year low

    $0.35
    BCTX price is currently +483.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $13.83M
    BCTX market capitalization is $13.83 million

    Market cap 3-year change

    +125.01%
    BCTX market capitalization is up +125.01% over the past 3 years

    Market cap All-time high

    $33.88M
    BCTX market capitalization is currently -59.19% below its historical high of $33.88 million

    Market cap sector rank

    20.08%
    BCTX market capitalization is higher than 20.08% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +455.87%
    BCTX shares outstanding is up +455.87% year-on-year

    Shares Outstanding 3-Year Change

    +555.01%
    BCTX shares outstanding is up +555.01% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -1.07
    BCTX beta is -1.07

    200-day SMA

    $2.43
    BCTX price is currently -16.03% below its 200-day simple moving average

    50-day SMA

    $3.24
    BCTX price is currently -36.98% below its 50-day simple moving average

    RSI

    23.39
    BCTX 14-day relative strength index is 23.39

    Volume

    2.25
    BCTX 30-day relative volume is 2.25

    ATR

    $0.22
    BCTX average true range is $0.22

    10-day Historical Volatility

    144.65%
    BCTX 10-day historical volatility is 144.65%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    BCTX annual revenue value is unknown

    Revenue Analysts estimate

    -
    BCTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    BCTX annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    BCTX annual revenue is unknown

    EPS

    EPS

    -$4.35
    BCTX annual earnings per share is -$4.35

    EPS Analysts estimate

    -$0.92
    BCTX annual earnings per share is currently +372.83% higher than the consensus analysts' forecast

    EPS 1-year change

    +77.69%
    BCTX annual earnings per share is up +77.69% year-on-year

    EPS Sector rank

    22.01%
    BCTX annual earnings per share is higher than 22.01% of companies in Healthcare sector

    Profit

    Gross profit

    -
    BCTX annual gross profit value is unknown

    Gross margin

    -
    BCTX annual gross profit margin value is unknown

    Operating profit

    -$33.33M
    BCTX annual operating income is -$33.33 million

    Operating margin

    -
    BCTX annual operating profit margin value is unknown

    Net income

    -$4.79M
    BCTX annual net profit is -$4.79 million

    Net margin

    -
    BCTX annual net profit margin value is unknown

    Expenses

    Total expenses

    $33.33M
    BCTX annual total expenses is $33.33 million

    Operating expenses

    $33.33M
    BCTX annual total operating expenses is $33.33 million

    Cost of goods sold

    -
    BCTX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $6.15M
    BCTX annual SGA is $6.15 million

    Depreciation and amortization

    $83.90K
    BCTX annual depreciation & amortization is $83.90 thousand

    Interest expense

    -
    BCTX annual interest expense value is unknown

    Income tax

    -
    BCTX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$33.33M
    BCTX annual earnings before interest & taxes is -$33.33 million

    EBITDA

    -$33.25M
    BCTX annual EBITDA is -$33.25 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.87M
    BCTX annual total assets is $5.87 million

    Non current assets

    $2.22M
    BCTX annual long term assets is $2.22 million

    Current assets

    $3.65M
    BCTX annual total current assets is $3.65 million

    Cash and cash equivalents

    $862.10K
    BCTX annual cash & cash equivalents is $862.10 thousand

    Accounts receivable

    -
    BCTX annual accounts receivable value is unknown

    Inventory

    -
    BCTX annual inventory value is unknown

    Liabilities

    Total liabilities

    $8.56M
    BCTX annual total liabilities is $8.56 million

    Long term liabilities

    $1.10M
    BCTX annual total long term liabilities is $1.10 million

    Current liabilities

    $7.46M
    BCTX annual total current liabilities is $7.46 million

    Accounts payable

    $7.17M
    BCTX annual accounts payable is $7.17 million

    Debt

    Total debt

    $0.00
    BCTX annual total debt is $0.00

    Total debt 1-year change

    0%
    BCTX {parameterFullLabel} has remained unchanged year-on-year

    Long term debt

    -
    BCTX annual long term debt value is unknown

    Short term debt

    -
    BCTX annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    -$2.38M
    BCTX annual stockholders equity is -$2.38 million

    Book value

    -$2.38M
    BCTX annual book value is -$2.38 million

    Retained earnings

    -$85.44M
    BCTX annual retained earnings is -$85.44 million

    Working capital

    -$3.81M
    BCTX annual working capital is -$3.81 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$24.13M
    BCTX annual cash flow from operations is -$24.13 million

    Cash from operations 1-year change

    -1.61%
    BCTX annual cash flow from operations is down -1.61% year-on-year

    Cash from investing

    -$681.80K
    BCTX annual cash flow from investing activities is -$681.80 thousand

    Cash from investing 1-year change

    -100%
    BCTX annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $4.42M
    BCTX annual cash flow from financing activities is $4.42 million

    Cash from financing 1-year change

    +11.75%
    BCTX annual cash flow from financing activities is up +11.75% year-on-year

    CAPEX

    CAPEX

    -
    BCTX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    BCTX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$24.58M
    BCTX annual free cash flow is -$24.58 million

    Free cash flow 1-year change

    -3.53%
    BCTX annual free cash flow is down -3.53% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BCTX annual gross profit margin value is unknown

    Operating margin

    -
    BCTX annual operating profit margin value is unknown

    Net margin

    -
    BCTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -81.59%
    BCTX annual return on assets is -81.59%

    ROE

    201.12%
    BCTX annual return on equity is 201.12%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BCTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BCTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.11
    BCTX price to book ratio is 1.11

    PB ratio Sector rank

    40.53%
    BCTX price to book ratio is higher than 40.53% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    BCTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BCTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.37M
    BCTX enterprise value is $1.37 million

    Enterprise value Sector rank

    12.5%
    BCTX enterprise value is higher than 12.5% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.03
    BCTX EV/EBITDA is -0.03

    EV/EBITDA Sector rank

    65.88%
    BCTX EV/EBITDA is higher than 65.88% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.49
    BCTX annual current ratio is 0.49

    Quick ratio

    -
    BCTX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    BCTX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    BCTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BCTX piotroski f-score value is unknown

    Altman Z-Score

    -
    BCTX altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Apr 22, 25 HC Wainwright & Co.
    Buy
    Feb 3, 25 HC Wainwright & Co.
    Buy
    Dec 12, 24 HC Wainwright & Co.
    Buy
    Dec 3, 24 HC Wainwright & Co.
    Buy
    Oct 3, 24 HC Wainwright & Co.
    Buy
    Sep 19, 24 HC Wainwright & Co.
    Buy
    Sep 11, 24 HC Wainwright & Co.
    Buy
    Jun 4, 24 HC Wainwright & Co.
    Buy
    May 24, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with BCTX included

    Growing Shares Outstanding
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for BriaCell Therapeutics Corp.?
    • Does BriaCell Therapeutics Corp. pay dividends?
    • What sector is BriaCell Therapeutics Corp. in?
    • What industry is BriaCell Therapeutics Corp. in?
    • What country is BriaCell Therapeutics Corp. based in?
    • When did BriaCell Therapeutics Corp. go public?
    • Is BriaCell Therapeutics Corp. in the S&P 500?
    • Is BriaCell Therapeutics Corp. in the NASDAQ 100?
    • Is BriaCell Therapeutics Corp. in the Dow Jones?
    • When was BriaCell Therapeutics Corp.'s last earnings report?
    • When does BriaCell Therapeutics Corp. report earnings?

    What is the ticker symbol for BriaCell Therapeutics Corp.?

    The ticker symbol for BriaCell Therapeutics Corp. is NASDAQ:BCTX

    Does BriaCell Therapeutics Corp. pay dividends?

    No, BriaCell Therapeutics Corp. does not pay dividends

    What sector is BriaCell Therapeutics Corp. in?

    BriaCell Therapeutics Corp. is in the Healthcare sector

    What industry is BriaCell Therapeutics Corp. in?

    BriaCell Therapeutics Corp. is in the Biotechnology industry

    What country is BriaCell Therapeutics Corp. based in?

    BriaCell Therapeutics Corp. is headquartered in Canada

    When did BriaCell Therapeutics Corp. go public?

    BriaCell Therapeutics Corp.'s initial public offering (IPO) was on March 14, 2012

    Is BriaCell Therapeutics Corp. in the S&P 500?

    No, BriaCell Therapeutics Corp. is not included in the S&P 500 index

    Is BriaCell Therapeutics Corp. in the NASDAQ 100?

    No, BriaCell Therapeutics Corp. is not included in the NASDAQ 100 index

    Is BriaCell Therapeutics Corp. in the Dow Jones?

    No, BriaCell Therapeutics Corp. is not included in the Dow Jones index

    When was BriaCell Therapeutics Corp.'s last earnings report?

    BriaCell Therapeutics Corp.'s most recent earnings report was on June 14, 2024

    When does BriaCell Therapeutics Corp. report earnings?

    The date for BriaCell Therapeutics Corp.'s next earnings report has not been announced yet
    On this page